.svg){kind=small}
Advances in Cardiovascular Science: From Discovery to Translation
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Basic Cardiovascular Sciences (BCVS) Scientific Sessions 2024,held from 22nd to 25th July in Chicago, Illinois.
This event features cutting-edge research and advancements in cardiovascular science, including topics like cardiac gene and cell therapy, tissue engineering, and cardiac metabolism.
Attendees will include basic cardiovascular scientists, molecular and cellular biologists, translational investigators, clinical trialists, and practicing cardiologists.
To connect with Dr. Taubel during the event, please reach out to arrange a meeting.
To find out more, click here.
-min.jpg)
.jpg)
Latest news
Richmond promotes new Director of Communications and Participant Engagement
August 12, 2024
Richmond Pharmacology is delighted to announce the promotion of Liz Romano to the new position of Director of Communications and Participant Engagement.
Read moreRichmond Chief Medical Director calls for a ‘toolbox’ of standards and guidelines for clinical trials
August 5, 2024
The British Journal of Clinical Pharmacology has published an editorial by Richmond’s Dr Ulrike Lorch and Professor Charles Vincent of Oxford University calling for a ‘toolbox’ of practical standards and guidelines for early phase clinical trials.
Read moreEvents
21st DIA Japan Annual Meeting 2024
27 - 29 October 2024
Dr. Jörg Taubel, along with colleagues Nobuo Ittetsu and Minoru Takada, will be attending the 21st DIA Japan Annual Meeting 2024.
View event
